A. Merz

Species-selective targeting of pathogens revealed by the atypical structure and active site of Trypanosoma cruzi histone deacetylase DAC2.

W. Sippl, C. Romier, S. Goldenberg, 2021, Cell reports.

Development of a NanoBRET assay to validate inhibitors of Sirt2-mediated lysine deacetylation and defatty-acylation that block prostate cancer cell migration

W. Sippl, R. Schüle, M. Jung, 2021, RSC chemical biology.

Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni

J. Keiser, C. Romier, M. Jung, 2022, ChemMedChem.

First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement

Aubry K. Miller, Raphael R. Steimbach, W. Sippl, 2022, Chembiochem : a European journal of chemical biology.